The global veterinary antimicrobial susceptibility testing market size was valued at USD 35.73 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2021 to 2028. The growing government initiatives and stringent regulatory guidelines are expected to propel the market growth over the forecast period. For instance, in 2022, new EU legislation will prohibit the use of all types of routine antibiotic usage of antibiotics in farming. The COVID-19 pandemic has had a very low impact on the market. However, the demand for antimicrobial susceptibility testing kits has been drastically lowered due to the reduced vet visits during the lockdown. The demand for animal protein and livestock products has also reduced during the first two quarters of 2020. The market showed a V-shaped recovery and vet visits became redeemed, which is bolstering the growth. According to IDEXX, the U.S. clinic visit increased by 6% in Q4 2020, which is expected to fuel the revenue growth over the forecast period.
According to OECD, the amount of antimicrobials used in food animals will increase from 63,151 tons to 105, 596 tons by 2030 globally. Approximately, 45mg of antimicrobials are used to produce 1 kg of beef. Moreover, 148mg of antimicrobials are used for 1 kg of chicken. The top 5 consumers of antimicrobials are China, the U.S., Brazil, India, and Germany, respectively. For instance, in the U.S., around 80% of the annual consumption of antimicrobials was for food animals in 2019.
The livestock population globally has been rapidly increasing. The demand for livestock products is growing in developing and developed countries. This has led to a rise in concerns over the health of livestock. According to the United States Department of Agriculture, National Agricultural Statistics Service, as of January 2021, the number of cattle and calves in the U.S. was 93,594,500 and that of the beef cow was 31,157,600. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. There is also an increasing demand for healthy, sustainable, and high-quality meat products, especially those with comparatively few or no antibiotics. This is, in turn, increasing the demand for antimicrobial susceptibility testing (AST).
Livestock animals, also known as production animals, held the largest share of over 64.0% in 2020. This can be attributed to the growing consumption of animal proteins and stringent regulations regarding the usage of antibiotics in food animals. China’s antibiotic consumption by the agriculture sector has decreased by around 58% from 2014 to 2019, according to the ministry bulletin. The Netherlands has decreased its antibiotics usage by around 56% within 5 years. The most common antibiotics used by farmers are for growth promotion.
The companion animals segment is expected to witness significant growth over the forecast period. An increase in the number of pet owners is driving the need for vaccinations for companion animals. According to the Pet Food Manufacturers Association, it is estimated that in 2020, 41% of households were estimated to own a pet in the U.K., accounting for 12 million pets. According to the Canadian Veterinary Medical Association, as of 2020, there were 8.1 million and 7.7 million households with cats and dogs, respectively. The most common antimicrobials used in companion animals are amoxicillin-clavulanate. The transmission of resistance through cats and dogs to humans is increasing at an alarming rate, which is further increasing the demand for antimicrobial susceptibility testing.
Automated AST instruments held the largest revenue share of over 41.0% in 2020. The growth can be attributed to the increasing adoption of these instruments and their higher cost as compared to other methods. Moreover, these instruments have improved the turnaround time and time of identification, which is propelling the growth. The instruments have advanced computer software to interpret susceptibility patterns for each organism and give error-free results.
Disks are most commonly used for AST in veterinary laboratories. The method uses small discs infused with specific concentrations of antibiotics to determine sensitivity. The method is time-consuming and the process is qualitative. This method is popular due to its cost and ease of operation. The other methods include the antimicrobial gradient method, intrinsic resistance, and acquired resistance.
Veterinary reference labs held the largest revenue share of over 55.0% in 2020 owing to the most number of testing of samples done under these facilities. These laboratories use diagnostic kits available in the market to serve pet owners, farm owners, government-related programs, or research collaborations. The antimicrobial susceptibility tests (ASTs) can provide essential information to select the most appropriate antimicrobials for a specific treatment. This will lead to the overall reduction of antimicrobial agents in animals.
The veterinary research institutes segment is expected to witness lucrative growth over the forecast period. The rising adoption of pet animals and increasing healthcare spending on pets are factors fueling the growth of research institutes and universities. The research institutes play a major role in the usage and development of these tests. The main functions taken care of by these research institutes include identification, deployment, and development of novel diagnostic techniques or procedures for research and monitoring purposes of newly emerging or existing diseases in animals and reduce the over-usage of antibiotics.
Asia Pacific held the largest share of over 33.0% in 2020 owing to the presence of a large livestock population in this region. Increasing demand for milk and animal-based protein and government initiatives are propelling the market growth in this region. Moreover, increasing adoption of pet animals, growing health concerns about pets, and increasing usage of antibiotics in animals are the factors driving the market in Asia Pacific countries, such as India and China. Furthermore, the market growth in the region can be attributed to the significantly high cattle population. For instance, China and India constitute more than 30% of the global population of cattle.
North America held the second-largest share in 2020 owing to the presence of major industry players. According to the FDA, as of 2017, the use of antibiotics for growth promotion in farm animals was banned in the U.S. USDA’s Food Safety and Inspection Service (FSIS) conducts a monitoring program for successful elimination of antibiotics from animals before slaughtering. Moreover, the market is anticipated to grow due to increasing animal healthcare centers and practitioners. For instance, according to the AVMA report, the country accounted for 116,091 veterinary practitioners in the year 2019; however, in 2020, the number increased to 118,624 practitioners in the country.
The market is fragmented with many large and small players. These players implement various strategic initiatives to achieve their objectives and increase market share. New product launches, regional expansion, partnerships, and mergers & acquisitions are some of the initiatives deployed by key companies. For instance, in February 2020, Becton, Dickinson and Company partnered with the Fleming Fund in order to help low and middle-income countries to handle antimicrobial resistance. In September 2019, Synbiosis launched AutoCol, an automated colony counter system, which would help to count colonies up to 100 plates within just 30 minutes. Some prominent players in the global veterinary antimicrobial susceptibility testing market include:
BioMérieux SA
Becton, Dickinson and Company
Synbiosis
Thermo Fisher Scientific
Bruker Corporation
Danaher Corporation
Condalab
Bioguard Corporation
Liofilchem S.r.l.
HiMedia Laboratories
Bio-Rad Laboratories
Neogen Corporation
Report Attribute |
Details |
Market size value in 2021 |
USD 37.16 billion |
Revenue forecast in 2028 |
USD 52.78 billion |
Growth Rate |
CAGR of 5.1% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million/billion & CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Animal type, product, end-use, region |
Regions covered |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
BioMérieux SA; Becton, Dickinson and Company; Synbiosis; Thermo Fisher Scientific; Bruker Corporation; Danaher Corporation; Condalab; Bioguard Corporation; LiofilchemS.r.l.; HiMedia Laboratories; Bio-Rad Laboratories; Neogen Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this report, Grand View Research has segmented the global veterinary antimicrobial susceptibility testing market report on the basis of animal type, product, end-use, and region:
Animal Type Outlook (Revenue, USD Million, 2016 - 2028)
Livestock Animals
Cattle
Poultry
Pigs
Others
Companion Animals
Cats
Dogs
Horses
Others
Product Outlook (Revenue, USD Million, 2016 - 2028)
Disks & Plates
Culture Media
Accessories & Consumables
Automated AST Instruments
End-use Outlook (Revenue, USD Million, 2016 - 2028)
Veterinary Reference Lab
Veterinary Research Institutes
Others
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
MEA
South Africa
b. The global veterinary AST market size was estimated at USD 35.73 billion in 2020 and is expected to reach USD 37.16 billion in 2021.
b. The global veterinary AST market is expected to grow at a compound annual growth rate of 5.1% from 2021 to 2028 to reach USD 52.78 billion by 2028.
b. Asia Pacific held the largest market share of over 33% in the veterinary AST market owing to the presence of a huge livestock population in this region. Increasing demand for milk and animal-based protein along with government initiatives are propelling the market growth in this region.
b. Some key players operating in the veterinary AST market are BioMérieux SA, Becton, Dickinson and Company, Synbiosis, Thermo Fisher Scientific, Bruker Corporation, Danaher Corporation, Condalab, Bioguard Corporation, Liofilchem S.r.l., HiMedia Laboratories, Bio-Rad Laboratories, Neogen Corporation.
b. Key factors that are driving the veterinary AST market growth include rising urbanization, increasing demand for healthy, sustainable, and high-quality meat products, especially those with comparatively few or no antibiotics.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."